Amr Aly focuses his practice on intellectual property litigation with emphasis on patent matters. His experience spans across several disciplines, including pharmaceutical, biotechnology, banking, Internet and chemical fields, and he has thorough knowledge of ANDA litigations. Mr. Aly has been involved in major complex litigations, including multi-party and multi-district litigations. Mr. Aly has been a key member of litigation teams that secured very favorable pre-trial results, which were affirmed by the Federal Circuit. Mr. Aly is the named inventor of U.S. Patent No. 4,999,225, entitled "Powder Thermal Spray Method for Spraying Non-Meltable Materials." He was a member of the 1984 U.S. Olympic Soccer Team and the U.S. National Soccer Team from 1980 to 1987. Prior to attending law school, Mr. Aly worked with major engineering companies for over ten years, gaining extensive experience in engineering and management. Mr. Aly speaks conversational Arabic. Industries Banking & Credit Unions; Pharmaceuticals; Telecommunications Experience TecSec Inc. v. IBM Corp., et al., Represents Cisco in a patent infringement litigation in the Eastern District of Virginia. The plaintiff asserted 11 patents related to encryption and network hardware technology against Cisco and several other defendants. In connection with defending Cisco, we performed significant analysis on the network hardware at issue. The court stayed the case for all defendants except for IBM, which won summary judgment of noninfringement. The case is currently on appeal to the Federal Circuit.
TecSec, Inc. v. IBM Corp., et al., No. 1:10-cv-115 (E.D. Va. filed Feb. 5, 2010). Patent litigation for a major provider of Internet access *, Represented a major provider of Internet access in a patent litigation suit. Secured summary judgment of invalidity of the patent in suit, which was affirmed by the Federal Circuit. Patent litigation for a major pharmaceutical company *, Represented a major pharmaceutical company by obtaining a finding that the plaintiff committed fraud on the Patent Office. Award of attorney's fees on behalf of a major pharmaceutical company *, Secured on behalf of a major pharmaceutical company an award of attorneys' fees against a generic manufacturer. Patent infringement litigation against International Securities Exchange, Served as lead counsel in representing International Securities Exchange (ISE) against patent infringement claims brought by the Boston Options Exchange (BOX) of an alleged patent covering price improvement for electronic financial trades. Our client had internal prior art that could be used to invalidate the asserted patent. We also threatened to counterclaim with a patent from ISE's portfolio that we assert covered BOX's options trading activity for similar price improvement electronic trade activities. The matter was settled on very favorable terms for our client ISE. Patent litigation for national telecommunications provider *, Represented a national telecommunications provider in a case that secured summary judgment of non-infringement. GellyFish Technology of Texas LLC v. T-Mobile USA Inc., et al., Represented T-Mobile, Sharp and Motorola Mobility against patent infringement claims. We filed detailed counterclaims demonstrating why the asserted patent is invalid in view of the prior art. The plaintiff dismissed the claims against all defendants. (Judge Folsom).
GellyFish Technology of Texas LLC v. Alltel Corp et al., No. 2:11-cv-00216 (E.D. Tex. filed Apr. 13, 2011). Patent troll litigation against T-Mobile USA Inc., Successfully defended T-Mobile USA, Inc., a wireless telecommunications carrier, in a patent troll case filed in the Eastern District of Texas relating to sound-effect features in mobile devices. We determined that our client possessed certain license rights to related patents. Case settled. Patent litigation for a major banking institution *, Represented a major banking institution against patent infringement allegations, securing a very favorable settlement. Patent litigation for health care products company *, Represented health care products company in patent infringement litigation. Played a key role in securing a jury verdict of noninfringement by limiting plaintiff's case at trial through motions in limine. *Experience gained by attorney prior to joining Kilpatrick Townsend Publications 01 March 2011, Federal Circuit Rejects Heightened Burden for Proving Infringement by Doctrine of Equivalents, Legal Alerts 26 February 2009, The Federal Circuit Certifies an Interlocutory Appeal to Consider the Issue of whether Markman Rulings Should Be Afforded Collateral Estoppel Effect, Legal Alerts 06 February 2009, Global Economic Environment Brings Extensive IP Developments, Source: New York Law Journal, Articles News 28 April 2011, Kilpatrick Townsend Welcomes United States Patent Trademark Office Director David Kappos, News Releases |